Medifast Inc
NYSE:MED
Medifast Inc
Other Equity
Medifast Inc
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medifast Inc
NYSE:MED
|
Other Equity
-$1k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Other Equity
-$1.3B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-16%
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Other Equity
-$3.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Coty Inc
NYSE:COTY
|
Other Equity
-$959m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
-17%
|
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Other Equity
-$72.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-16%
|
|
|
elf Beauty Inc
NYSE:ELF
|
Other Equity
$183k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medifast Inc
Glance View
Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.
See Also
What is Medifast Inc's Other Equity?
Other Equity
-1k
USD
Based on the financial report for Dec 31, 2024, Medifast Inc's Other Equity amounts to -1k USD.
What is Medifast Inc's Other Equity growth rate?
Other Equity CAGR 1Y
98%
Over the last year, the Other Equity growth was 98%.
You don't have any saved screeners yet